299.80↑-0.05 (-0.02%)
03:53 PM,29th Nov 2023301.70↑2.10 (0.70%)
04:01 PM,29th Nov 2023BSE : 509079
NSE : GUFICBIO
Sector : Health care
ISIN Code : INE742B01025
Last Updated: Nov 29 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 3006 |
Turnover (₹ Cr) | 0.24 |
Volume (Shares) | 80058 |
Face Value | 1 |
52-WK High | 333.00 |
52-WK High Date | 01 Sep 2023 |
52-WK Low | 177.65 |
52-WK Low Date | 28 Mar 2023 |
All Time High | 333.00 |
All Time High Date | 01 Sep 2023 |
All Time Low | 2.55 |
All Time Low Date | 12 Mar 2009 |
Gufic Biosciences (GBL) was incorporated in Jul'84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients generic pharmaceuticals and related services. The Choksi and Gandhi family the promoters of GBL have a long-standing presence in the pharma industry. In 1960 the family set up a joint venture company called Lyka Labs. In 1976 they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently the overall profile of GBL comprises ethical products herbal products consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins) Onergy and Stretch nil.In the year 2000 the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a seller's market. The company plan to invest further in R&D activities and aggressively enter the herbal product and consumer product segments where it foresee a huge potential. While benefiting from the rich traditional knowledge base in India it would like to operate from an area of strength in the herbal products segment.In 2020-21 Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21 2021. GUFIC UK LIMITED (GUL) a wholly owned subsidiary of the Company was incorporated in United Kingdom on March 15 2022. Similarly in 2023 Gufic Ireland Limited (GIL) was incorporated on March 02 2023.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 3006 |
EPS - TTM (₹) [S] | 8.20 |
P/E Ratio (X) [S] | 6.13 |
Face Value (₹) | 1 |
Latest Dividend (%) | 10.00 |
Latest Dividend Date | 21 Sep 2023 |
Dividend Yield (%) | 0.03 |
Book Value Share (₹) [S] | 48.93 |
P/B Ratio (₹) [S] | 6.13 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|---|---|---|
Groww Nifty Total Market Index Fund-Regular (G) | 0.00 | 61 | 0.00 |
Groww Nifty Total Market Index Fund-Direct (G) | 0.00 | 61 | 0.00 |
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 297.20 304.90 |
Week Low/High | 294.05 315.00 |
Month Low/High | 250.60 315.00 |
Year Low/High | 177.65 333.00 |
All time Low/High | 0.17 333.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.06% | -2.71% | 1.33 | 1.44% |
1 Month | 17.85% | 17.96% | 4.89 | 5.51% |
3 Month | -1.82% | -1.56% | 2.81 | 3.90% |
6 Month | 42.12% | 42.63% | 6.45 | 8.05% |
1 Year | 40.00% | 39.77% | 6.73 | 7.94% |
3 Year | 156.68% | 156.46% | 51.53 | 54.96% |
Chairman & Managing Director : Jayesh P Choksi
Whole Time Director & CEO : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Non-Exec. & Independent Dir. : Shreyas Patel
Company Sec. & Compli. Officer : Ami Naresh Shah
Non-Exec. & Independent Dir. : Gopal Daptari
Non-Exec. & Independent Dir. : Shrirang V Vadiya
Non-Exec & Non-Independent Dir : Balram Singh
Non-Exec. & Independent Dir. : Rabi Narayan Sahoo
Non-Exec. & Independent Dir. : Anusanjiv Aurora
Whole-time Director : Dilip Ghosh
Registered Office: Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E,Mumbai,Maharashtra-400069 Ph: 91-022-66919187/67261007/66919189
Email:info@guficbio.com